• Anti-IgA antibody [N1CLA] (STJ16101750)

Anti-IgA antibody [N1CLA] (STJ16101750)

SKU:
STJ16101750-1

Shipping:
Free Shipping
Current Stock:
Host: Mouse
Applications: IHC-P
Reactivity: Human
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: Mouse monoclonal antibody anti-Immunoglobulin A is suitable for use in Immunohistochemistry research applications.
Clonality: Monoclonal
Clone ID: N1CLA
Conjugation: Unconjugated
Isotype: IgG1
Formulation: Tissue culture supernatant with Sodium azide
Concentration: >=46 mg/L
Dilution Range: IHC-P 1:300
Storage Instruction: Store at 2-8°C upon receipt.
Immunogen: Prokaryotic recombinant protein corresponding to 129 amino acids of the heavy chain constant region of the human immunoglobilin A molecule
Background IgA is a member of the antibody class of the immunoglobulin superfamily. There are several classes and subclasses (isotypes) of antibody, the antibody isotype being defined by the immunoglobulin heavy chain present in the molecule. The basic structure of an immunoglobulin molecule consists of two identical heavy chains (gamma, mu, alpha, delta, epsilon) and two identical light chains, either kappa or lambda. IgA contains the alpha-chain and may be present in a serum or secretory form. In serum, 90% of IgA is monomeric, while in its secretory form it is the main immunoglobulin found in secretions including tears, saliva, intestinal and bronchial mucous, sweat, colostrum, and secretions from the prostate and respiratory epithelia, where it has the job of defending exposed external surfaces of the body against attack from micro organisms. Secretory IgA is synthesized locally by plasma cells and dimerized intracellularly with a cysteine-rich J-chain. Clone N1CLA was developed to produce reduced background staining that is associated with polyclonal antibodies on paraffin sections.

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance